Ten-Year Follow-Up of a Randomized Trial of Pravastatin in Heart Transplant Patients

The 10-year follow-up of this study suggests that the use of pravastatin in heart transplant patients maintains survival benefit and appears to reduce the development of cardiac allograft vasculopathy.